Key Financial Figures

Standalone Financial Position (as at March 31, 2026 vs March 31, 2025):

  • Total Assets: ₹455.12 crores (₹452.41 crores)
  • Total Equity: ₹420.89 crores (₹419.67 crores)
  • Total Liabilities: ₹34.23 crores (₹32.74 crores)
  • Property, Plant and Equipment: ₹54.64 crores (₹55.34 crores)
  • Investments: ₹309.71 crores (₹293.52 crores)
  • Assets held for sale: ₹64.07 crores (₹64.46 crores)

Standalone Financial Performance (FY 2026 vs FY 2025):

  • Profit before exceptional items and tax: ₹1.56 crores (₹5.45 crores)
  • Exceptional items: ₹(2.00) crores (₹(1.80) crores)
  • Profit before tax: ₹6.92 crores (₹(5.70) crores)
  • Tax expense: ₹(0.88) crores (₹0.19 crores)
  • Net Profit: ₹7.85 crores (₹(5.89) crores)
  • Total comprehensive income: ₹7.40 crores (₹(2.17) crores)

Consolidated Financial Position (as at March 31, 2026 vs March 31, 2025):

  • Total Assets: ₹842.83 crores (₹924.10 crores)
  • Total Equity: ₹196.73 crores (₹214.22 crores)
  • Non-controlling interest: ₹(122.59) crores (₹(124.59) crores)
  • Total Liabilities: ₹768.69 crores (₹834.47 crores)
  • Borrowings: ₹449.72 crores (₹451.47 crores)

Consolidated Financial Performance (FY 2026 vs FY 2025):

  • Loss before exceptional items and tax: ₹(17.66) crores (₹(37.26) crores)
  • Exceptional items: ₹(3.80) crores (₹(6.05) crores)
  • Loss before tax: ₹(21.46) crores (₹(43.31) crores)
  • Tax expense: ₹(4.12) crores (₹(15.22) crores)
  • Net Loss: ₹(17.29) crores (₹(28.13) crores)
  • Total comprehensive income: ₹(13.77) crores (₹(28.39) crores)

Corporate Actions and Transactions

Dividend Declaration:

The Board of Directors did not recommend any dividend for the year ended March 31, 2026.

Preference Share Redemption:

  • The company redeemed 1,56,00,000 preference shares of Caprihans India Limited
  • Redemption occurred in two tranches: 78,00,000 shares on May 28, 2026 and 78,00,000 shares on May 29, 2026
  • Aggregate redemption value: ₹15.60 crores
  • These were 0.1% Non-Cumulative, Non-Participating Redeemable Preference Shares of ₹10/- each

Warrant Conversion and Equity Allotment:

  • Converted 10,40,000 warrants into equity shares of Caprihans India Limited
  • Each warrant was convertible into one equity share of ₹10/- at ₹200/- each
  • Allotment occurred in two tranches: 5,20,000 shares on May 28, 2026 and 5,20,000 shares on May 29, 2026
  • Shareholding in Caprihans increased from 59.56% to 62.04%
  • Pre-conversion holding: 94,78,325 shares (59.56%)
  • Post-conversion holding: 105,18,325 shares (62.04%)

Regulatory and Compliance Matters

SEBI Regulations:

  • Disclosure made pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
  • Declaration provided pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2016

Contingent Liabilities and Legal Matters

CSIR Loan:

  • Penal interest of ₹17.72 crores on CSIR loan disclosed as contingent liability
  • Matter subjudice before Hon'ble High Court of Delhi
  • Court order dated March 20, 2026 stayed arbitral award based on Maharashtra Relief Undertakings notification dated December 22, 2025
  • Company recognizes outstanding principal and simple interest at 3% per annum as contractual obligation

Fixed Deposit Liability:

  • Public fixed deposit liability taken over by Caprihans India Limited per Business Transfer Agreement
  • Company responsible for statutory compliances
  • Additional interest on cumulative fixed deposits recognized as interest cost

SFIO Investigation:

  • Company under investigation by SFIO
  • Matter remains sub-judice as of reporting date

Labour Code Impact:

  • Government notified four Labour Codes on November 21, 2025
  • Incremental impact assessed at ₹0.05 crore for gratuity and ₹0.0036 crore for leave compensated absences
  • Presented under exceptional items due to regulatory-driven, non-recurring nature

Accounting Policies and Notes

Basis of Preparation:

  • Prepared in accordance with Indian Accounting Standards (Ind AS)
  • Accounts prepared on going-concern basis
  • Positive prospects for GCS business cited as rationale

Significant Accounting Treatments:

  • Land parcels with book value of ₹64.07 crores classified as Assets Held for Sale
  • Corporate guarantee of ₹3,666.96 crores provided for subsidiary Caprihans India Limited
  • No current tax provision due to unabsorbed carried forward losses
  • Deferred tax assets not recognized due to unabsorbed losses
  • Lease arrangements reviewed and restated with impact of ₹0.008 crores to Retained Earnings

Consolidated Financials:

  • Includes subsidiaries: Caprihans India Limited, Bilcare Pharma Solutions Limited, Bilcare GCS Ireland, Bilcare GCS Inc. US, Bilcare Inc. US, and Bilcare Research GmbH
  • Property, Plant and Equipment of subsidiary considered at cost, reversing Revaluation Reserve of ₹499.88 crores
  • Impact increased current year profit by ₹27.67 crores
  • EPS for year ended March 31, 2026: ₹0.73 (compared to earlier ₹(11.02))

Board Meeting Details

  • Meeting held on Friday, May 29, 2026
  • Commenced at 15:30 IST and concluded at 23:55 IST
  • Results reviewed by Audit Committee and approved by Board of Directors

#Tags: #BilcareLimited #FY2026Results #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Neutral